Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiovascular Diseases: full-pipeline trial registry
134 of 304 indexed Cardiovascular Diseases trials are currently recruiting.
Corpus placement: #27 of 28,707 conditions by registered trial count.
304 US clinical trials · 134 currently recruiting · #27 of 28,707 conditions by registered trial count
Cardiovascular Diseases: 304 US clinical trials tracked, 134 recruiting.
Cardiovascular Diseases is the subject of 304 registered US clinical trials on ClinicalTrials.gov, 134 of them currently open to new participants. 26 are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most active sponsor is Duke University, running 10 of these trials.
Enrollment posture brief
Registry condition cardiovascular-diseases
OPEN 134 | RECR 44% | LATE 26 | EARLY 28 | RANK #27 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Suicide (44% recruiting · 93 trials)
Cardiovascular Diseases lists 134 open slots (44% of 304 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiovascular Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiovascular Diseases is recruiting above its size-band peers.
134 of 304 indexed trials (44.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cardiovascular Diseases trials is spread across many organizations.
Duke University accounts for 10 of 304 trials (3.3%). 159 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiovascular Diseases enrolment sits around 200 participants.
Median target enrolment is 200 among the 301 trials that report a genuine target (sentinel values excluded). 101 of those (33.6%) plan for fewer than 100 participants.
-
Cardiovascular Diseases research is mostly interventional.
225 interventional and 79 observational studies make up this index (74% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
304 total, page 5 of 7
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
Tufts Medical Center
NCT00091507
A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Eli Lilly and Company
NCT00059215
Understanding the Impact of Neighborhood Type on Physical Activity in Older Adults
Stanford University
NCT00094211
Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
Boston Medical Center
NCT00201149
ISCHEMIA-Chronic Kidney Disease Trial
NYU Langone Health
NCT01985360
CV Disease in Adolescents With Type 2 Diabetes
Children's Hospital Medical Center, Cincinnati
NCT00114998
Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes
University of Rochester
NCT00508014
Heart Rate Variability and Sudden Cardiac Death
Columbia University
NCT00005235
Physician Uncertainty Reduction for Hypertension
Baylor College of Medicine
NCT00201084
Comparison of Two Methods to Diagnose Coronary Artery Disease
Johns Hopkins University
NCT00063531
Solutions for Atrial Fibrillation Edvocacy (SAFE)
American Pharmacists Association Foundation
NCT05067114
Reducing Disparities in Primary Prevention of Cardiovascular Disease
Northwestern University
NCT01610609
Promoting Healthy Lifestyles Among Firefighters
Oregon Health and Science University
NCT00006181
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
CardioDx
NCT01117506
Targeting of UnControlled Hypertension in Emergency Department
University of Illinois at Chicago
NCT03749499
LEAVE Safe With DOACs
University of Massachusetts, Worcester
NCT04068727
HUDDLE: Heart Health: Understanding & Diagnosing Disease by Leveraging Echocardiograms
Edwards Lifesciences
NCT05009589
Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention
University of Pennsylvania
NCT02508116
Global Profiling of Gene and Protein Expression Associated With Coronary Heart Disease Reversal
Windber Research Institute
NCT01805492
Behavioral and Recovery Support for 30 Day Post-Discharge Care
Laguna Health
NCT05431894
Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise
Iowa State University
NCT03069092
Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial
CardioDx
NCT00583297
Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
Duke University
NCT00041392
Reducing Risk Factors in Peripheral Arterial Disease
Northwestern University
NCT00217919
Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications
University of Colorado, Denver
NCT05166382
pRESET for Occlusive Stroke Treatment
phenox
NCT03994822
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
University of Washington
NCT00880178
Estrogen, HDL, and Coronary Heart Disease in Women
Tufts University
NCT00083824
Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors
PHCC
NCT00796172
School-Based Intervention to Increase Physical Activity Among Adolescent Females
National Heart, Lung, and Blood Institute (NHLBI)
NCT00296101
Predictive Medicine Research. (PRE MED)
Emory University
NCT00336570
Effects of Resistance and Aerobic Exercise on Cardiovascular Health
Duke University
NCT00275145
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
Cordis US
NCT01355406
Veterans Walk for Health Study
US Department of Veterans Affairs
NCT00123435
Pharmacist-led Group Medical Visits to Help With Diabetes Management
VA Office of Research and Development
NCT00554671
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
Baylor Research Institute
NCT00224809
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
Duke University
NCT06278883
Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study
University of Michigan
NCT04587882
Healthy Lifestyle Behavior Intervention for Latino Women
University of California, Los Angeles
NCT01333241
Epidemiology of Hypertensive Emergency
Columbia University
NCT00005240
Diabetes Remote Intervention to improVe Use of Evidence-based Medications
Brigham and Women's Hospital
NCT06046560
Heartmatters Challenge - First Responders
Boston Heart Diagnostics
NCT03322046
Comparing TR Band to Statseal in Conjunction With TR Band
VA Long Beach Healthcare System
NCT03028025
Sapphire 3 CTO Study
OrbusNeich
NCT06358508
Strong People Strength Training Study
Cornell University
NCT04203563
Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers
University of Miami
NCT00253682
Worksite Wellness Within Long-term Care Facilities
University of Maryland, Baltimore
NCT04166643
Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians
Black Hills Center for American Indian Health
NCT00608387
Comparison of Hematocrit Levels in Infant Heart Surgery
National Heart, Lung, and Blood Institute (NHLBI)
NCT00006183
Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk
National Heart, Lung, and Blood Institute (NHLBI)
NCT00613158
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 18 |
| Phase 3 | 13 |
| Phase 4 | 13 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiovascular Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiovascular Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiovascular Diseases page
304 registered trials, 134 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 134 Cardiovascular Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Duke University sponsors the most Cardiovascular Diseases trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiovascular Diseases condition card totals 304 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.